Tue.Feb 21, 2023

article thumbnail

Young Children Benefit from 3 Doses of Pfizer-BioNTech COVID-19 Vaccine

Drug Topics

The vaccine was 73.2% effective in children aged 6 months to 4 years when administered during the Omicron-dominant phase.

Vaccines 469
article thumbnail

What they are saying: Nonprofit hospitals are gaming the system at the expense of patients

PhRMA

There have been some alarming stories uncovered by the media on ways nonprofit hospitals — many of which participate in the 340B drug pricing program — are taking advantage of the system and their tax-exempt status to boost their bottom lines, at the expense of patients.

Hospitals 306
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Kindergarten Vaccination Rates Falling, Creates Opportunity to Offer Catch-Up Vaccine Schedules

Drug Topics

With nearly 250,000 kindergarten age children not receiving their recommended vaccines, pediatric health care providers search for solutions.

Vaccines 467
article thumbnail

Why the pharma industry is digging deep in rare disease

PharmaVoice

The rare disease market is set for major growth in the decade to come, and pharma companies are securing their footholds now.

245
245
article thumbnail

From Diagnosis to Delivery: How AI is Revolutionizing the Patient Experience

Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.

The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven

article thumbnail

Does a Prior COVID-19 Infection Protect Patients from Reinfection?

Drug Topics

Researchers estimate the protection from COVID-19 reinfection based on the variant and time since a patient's previous infection.

464
464
article thumbnail

Biotechs teeter on unsteady ground in 2023 and some may close shop

PharmaVoice

A slew of early stage biotechs were forced to shut down last year as the market tanked. Will the trend continue?

147
147

More Trending

article thumbnail

Medicinal cannabis: the route to good manufacturing practice registration

European Pharmaceutical Review

The UK medicinal cannabis sector has witnessed important regulatory advances in recent years. After the substance became legal in the UK in 2018, pharmaceutical companies have faced numerous obstacles to attain a fairer position in the industry. Crucially, January 2023 marked a key moment: the Medicines and Healthcare products Regulatory Agency (MHRA) granted Celadon Pharmaceuticals the first good manufacturing practice (GMP) registration since legalisation in 2018 for high Δ9-tetrahydrocannabin

article thumbnail

STAT+: How a depression test devised by a Zoloft marketer became a crutch for a failing mental health system

STAT

A bedrock of the U.S. mental health system — a nine-item questionnaire used to spot depression — began not with a doctor, but with a marketing man. Howard Kroplick, now 73 years old and living on Long Island, is obsessed with antique racing cars and, in his storied career in the pharmaceutical industry, crucially urged Pfizer to avoid the word “impotence” when promoting Viagra.

125
125
article thumbnail

European Pharmaceutical Review Issue 1 2023

European Pharmaceutical Review

Included in this issue of European Pharmaceutical Review : FOREWORD Accelerating drug development David Elder, David P Elder Consultancy RAMAN SPECTROSCOPY Shining a light on Raman for microbiological analysis Tim Sandle, Bio Products Laboratory LIMS Overcoming barriers to capturing data in a laboratory Samantha Kanza, University of Southampton ENVIRONMENTAL MONITORING Endotoxin trends: sustainability, automation and beyond Miriam Guest, AstraZeneca UK REGULATORY INSIGHT UPC opt-out – a strateg

111
111
article thumbnail

2023 hair care trends

Drug Store News

Consumers are obsessed with their hair, whether it be washing, styling, removing or growing. Here are what experts predict will keep sales bouncy in the new year.

109
109
article thumbnail

Position Your Pharmacy for Expansion

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.

article thumbnail

Office for Civil Rights brings 2 reports to Congress regarding state of HIPAA compliance and cybersecurity

Fierce Healthcare

Office for Civil Rights brings 2 reports to Congress regarding state of HIPAA compliance and cybersecurity aburky Tue, 02/21/2023 - 14:54

HIPAA 106
article thumbnail

AAM names 2023 board of directors

Drug Store News

Christine Baeder, senior vice president and chief operating officer for U.S. generics, Teva Pharmaceuticals USA is the 2023 AAM chair of the board.

106
106
article thumbnail

Program promises to take a team approach to tackling severe kidney disease

Fierce Healthcare

Program promises to take a team approach to tackling severe kidney disease fdiamond Tue, 02/21/2023 - 09:48

106
106
article thumbnail

EC approves first gene therapy for haemophilia B

European Pharmaceutical Review

A conditional marketing authorisation (CMA) has been granted by the European Commission (EC) for HEMGENIX ® (etranacogene dezaparvovec), the first and only one-time gene therapy for haemophilia B (congenital Factor IX deficiency). The treatment is indicated for severe and moderately severe forms of the condition in adults without a history of Factor IX inhibitors.

Hospitals 105
article thumbnail

What the FDA's New Dosage Guidance Means for the Future of Clinical Research

Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist

What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.

article thumbnail

CMS: Tighter price transparency enforcement, standardized requirements for hospitals are on the horizon

Fierce Healthcare

CMS: Tighter price transparency enforcement, standardized requirements for hospitals are on the horizon dmuoio Tue, 02/21/2023 - 15:15

Hospitals 106
article thumbnail

Identifying bacterial isolates to help prevent cleanroom contamination

European Pharmaceutical Review

A paper has found that nearly 70 percent of bacterial isolates identified in a study were attributed to operator contamination within a cleanroom facility. Published in the European Journal Of Parenteral And Pharmaceutical Sciences (EJPPS), the research sought to determine identity of representative bacterial isolates recovered from the surface of cleanroom operators’ garments following wear.

104
104
article thumbnail

Opinion: Tobacco companies pledge ‘harm reduction’ but are doing the opposite

STAT

This year could shape up to be a historic one for tobacco control — or one in which Big Tobacco accelerates its steady transformation into Big Nicotine. We are hoping for the former, but aren’t betting against the latter. For the last few years, the tobacco industry has publicly endorsed harm reduction. This public health strategy includes efforts designed to reduce, though not eliminate, risks for people who engage in harmful behaviors.

101
101
article thumbnail

Senators urge CMS to rethink narrow Medicare coverage for Alzheimer's drugs

Fierce Healthcare

Senators urge CMS to rethink narrow Medicare coverage for Alzheimer's drugs pminemyer Tue, 02/21/2023 - 16:17

98
article thumbnail

5 Reasons to Upgrade Your Pharmacy Management Software

Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.

article thumbnail

STAT+: ‘Practice changing’: Antibody treatment benefits leukemia patients receiving bone marrow transplant

STAT

An experimental antibody that delivers lethal radiation directly to the bone marrow improved the outcomes of stem cell transplants for older patients with relapsed leukemia — and may change the way transplant medicine is practiced. The antibody-radiation treatment, called Iomab-B, is being developed by Actinium Pharmaceuticals, a small drugmaker based in New York.

100
100
article thumbnail

Psychedelics, Pregnancy, and Breastfeeding

The Spirit Pharmacist

No high-quality data is available to guide our understanding of the benefits and risks of psychedelic use during pregnancy. However, there are some good reasons to discuss psychedelic use in pregnancy or breastfeeding. My aim was to review medical literature regarding psychedelics and pregnancy and report the results. There may be certain topics mentioned with one psychedelic and not another.

article thumbnail

Hong Kong pulls visa for ‘CRISPR babies’ scientist He Jiankui

STAT

BEIJING — Hong Kong on Tuesday revoked a visa it granted to a Chinese scientist who set off an ethical debate five years ago with claims that he made the world’s first genetically edited babies, pulling it hours after he announced his research plans in the financial hub. He Jiankui shocked the world in 2018 when he announced he had altered the embryos of twin girls, with many in the scientific community criticizing his work as unethical.

98
article thumbnail

Alembic launches generic Latuda

Drug Store News

Generic Latuda is used to treat a depressive episode associated with Bipolar I Disorder (bipolar depression) in adults and pediatric patients as monotherapy.

98
article thumbnail

STAT+: Pharmalittle: Cystic fibrosis patients caught in battle between pharma and insurers; Merck Covid pill fails to prevent infection among household members

STAT

Good morning, everyone, and welcome to another working week. Like many on this side of the pond, we are returning from an extended weekend respite, which we hope was invigorating and relaxing, thanks to a holiday. Now, though, the time has come to return to the usual routine of deadlines, meetings and online calls. But what can you do? The world, such as it is, keeps spinning.

article thumbnail

GNC rolls out Total War Black Ops Extreme Pre-Workout

Drug Store News

Redcon1’s Total War Black Ops Extreme Pre-Workout is an ultra-dosed product formulated to support extreme and high-intensity workouts.

98
article thumbnail

STAT+: Dutch group sues AbbVie for human rights violations stemming from Humira pricing

STAT

A Dutch public interest group has filed a lawsuit claiming AbbVie breached a duty to human rights by using unfair and excessive pricing to bolster sales of its Humira drug and dominate the market at the expense of the health care system in the Netherlands. In making its case, the Pharmaceutical Accountability Foundation argued AbbVie allegedly overcharged the Dutch health care system by up to $1.2 billion by “abusing” its position in the marketplace and keeping prices high.

98
article thumbnail

FDA approves first treatment for geographic atrophy

European Pharmaceutical Review

SYFOVRE (pegcetacoplan injection) is the first and only treatment approved by the US Food and Drug Administration (FDA) for geographic atrophy (GA), a leading cause of blindness. GA is an advanced form of age-related macular degeneration (AMD). It is a progressive and irreversible disease caused by the growth of lesions, which destroy the retinal cells responsible for vision.

FDA 98
article thumbnail

New COVID-19 Website Pharmacists Can Use to Educate Patients

Drug Store News

Roche Diagnostics and Pfizer are collaborating to offer a new resource that supports consumers, pharmacists and other healthcare professionals by offering access to critical information, including how to locate resources about testing, available trea

98
article thumbnail

Pfizer’s Covid-19 vaccine sales forecasts upgraded with sales of $37bn in 2022

Pharmaceutical Technology

Pfizer and BioNTech’s Covid-19 vaccine, Comirnaty, had a phenomenal year with forecast sales of $37bn in 2022. Comirnaty is expected to maintain the sales dominance it saw during the Covid-19 pandemic going into the future, with the average annual sales forecast rising by 19% between H1 and H2 2022, according to GlobalData’s Coronavirus Disease 2019 (Covid-19) Sector Forecast: H2 2022 Global Analyst Consensus Sales Forecast report.

article thumbnail

Kroger, Albertsons reportedly moving forward on plans to divest stores

Drug Store News

The stores that Kroger and Albertsons reportedly may sell are estimated to be worth more than $1 billion, according to a Reuters report.

98
article thumbnail

UnitedHealth's $5.4B LHC Group buy set to close this week

Fierce Healthcare

UnitedHealth's $5.

97
article thumbnail

Watch DSN: Walgreens pharmacists on the frontlines of patient testing services

Drug Store News

Drug Store News interviewed Anita Patel, vice president of pharmacy services development at Walgreens, about how the retailer is utilizing pharmacists in patient care and testing.

article thumbnail

Merck's COVID pill Lagevrio comes up short in household COVID exposure study

Fierce Pharma

Merck's COVID pill Lagevrio comes up short in household COVID exposure study kdunleavy Tue, 02/21/2023 - 10:18

90
article thumbnail

Walmart’s Q4 boasts strong store, e-commerce operations

Drug Store News

The company reported total revenue of $164.0 billion, an increase of 7.3%, or 7.9% in constant currency.

94